Wave Life Sciences

Wave surfs DMD success to regulators' doors, sending stock up
Fierce Biotech
Tue, 09/24/24 - 11:45 am
Wave Life Sciences
DMD
Duchenne Muscular Dystrophy
clinical trials
Wave, with new data, plots path forward for Huntington’s drug
BioPharma Dive
Tue, 06/25/24 - 09:08 pm
Wave Life Sciences
Huntington's disease
antisense
WVE-003
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
First RNA Editing Therapy Nears Clinic as Excitement Mounts
BioSpace
Mon, 10/9/23 - 10:21 am
Wave Life Sciences
WVE-006
RNA editing
alpha-1 antitrypsin deficiency
Wave readies clinical testing for first RNA editing therapy
BioPharma Dive
Tue, 09/5/23 - 08:40 pm
Wave Life Sciences
RNA editing
Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target
Fierce Biotech
Tue, 05/23/23 - 11:41 am
Wave Life Sciences
antisense
WVE-004
clinical trials
ALS
dementia
'It's the right call': GSK expresses no regrets on abandoning cell therapy as oligo strategy heats up
Fierce Biotech
Fri, 02/17/23 - 09:46 am
GSK
cell therapy
gene therapy
oligonucleotides
Wave Life Sciences
GSK Strikes $3.3B Oligonucleotide Pact with Wave Life Sciences
BioSpace
Wed, 12/14/22 - 10:21 am
GSK
oligonucleotide
Wave Life Sciences
PRISM technology
Takeda, Wave Life Sciences revise their $230M R&D collaboration, dropping discovery work
Endpoints
Tue, 10/19/21 - 10:51 am
Takeda
Wave Life Sciences
R&D
Wave culls leading Huntington's meds as shares go under after rival Roche hit by similar fate
Fierce Biotech
Tue, 03/30/21 - 11:36 am
Wave Life Sciences
Huntington's disease
Wave gets another shot at Huntington’s
EP Vantage
Mon, 03/22/21 - 10:39 am
Wave Life Sciences
WVE-120102
Huntington's disease
First-quarter catalysts for the smaller players
EP Vantage
Fri, 12/18/20 - 10:54 am
FDA
Supernus
Wave Life Sciences
Rhythm
Calithera
Matinas
Regenexbio
Wave Life Sciences hits tumultuous waters as ax comes crashing down on staffers
Fierce Biotech
Mon, 02/10/20 - 10:31 am
Wave Life Sciences
layoffs
Duchenne Muscular Dystrophy
Clinical developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:35 pm
Google Health
Axsome
Spectrum Pharmaceuticals
Wave Life Sciences
Google DeepMind
AXS-07
WVE-120102
poziotinib
Wave tanks again as Huntington's clinical trial data underwhelm
Fierce Biotech
Thu, 01/2/20 - 10:54 am
Wave Life Sciences
Huntington's disease
clinical trials
WVE-120102
Wave Stock Crashes After Decision to Halt Duchenne Drug Studies
Xconomy
Mon, 12/16/19 - 10:35 pm
Wave Life Sciences
Duchenne Muscular Dystrophy
suvodirsen
clinical trials
Wave faces key test in bid to challenge Sarepta in DMD
Biopharma Dive
Sat, 11/30/19 - 11:18 pm
Wave Life Sciences
Sarepta Therapeutics
Exondys 51
Duchenne Muscular Dystrophy
Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
EP Vantage
Fri, 11/15/19 - 11:14 am
Wave Life Sciences
WVE-120101
Huntington's disease
Argenx
efgartigimod
autoimmune disease
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Sat, 09/21/19 - 12:28 pm
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
Wave takes a different tack from Sarepta in Duchenne
EP Vantage
Thu, 09/12/19 - 10:33 am
Wave Life Sciences
Duchenne Muscular Dystrophy
suvodirsen
Sarepta Therapeutics

Pages